Determination of bevantolol enantiomers in human plasma by coupled achiral-chiral high performance-liquid chromatography.

A coupled achiral-chiral high performance liquid chromatographic method was developed and fully validated for the determination of bevantolol enantiomers, (-)-(S)-bevantolol and (+)-(R)-bevantolol, in human plasma. Plasma samples were prepared by solid phase extraction with Sep-Pak Plus C18 cartridges followed by HPLC. Bevantolol enantiomers and (+)-(R)-Propranolol as internal standard (IS) were preseparated from interfering components in plasma on a Phenomenex silica column and bevantolol enantiomers and IS were resolved and determined on a Chiralcel OJ-H chiral stationary phase. The two columns were connected by a switching valve equipped with silica precolumn. The Precolumn was used to concentrate bevantolol in the eluent from the achiral column before back flushing onto chiral phase. A detailed validation of the method was performed accordingly to FDA guidelines. For each enantiomer the assay was linear between 20 and 1600 ng/ml. The quantification limits of both bevantolol enantiomers were 20 ng/ml. The intraday variation was between 1.07 and 12.64% in relation to the measured concentration and the interday variation was 0.91 and 11.79%. The method has been applied to the determination of (-)-(S)- and (+)-(R)-bevantolol in plasma from healthy volunteers dosed with racemic bevantolol hydrochloride. Copyright (c) 2007 Wiley-Liss, Inc.

Citation

Joung Weon Oh, Tran Quoc Trung, Kwan Seog Sin, Jong Seong Kang, Kyeong Ho Kim. Determination of bevantolol enantiomers in human plasma by coupled achiral-chiral high performance-liquid chromatography. Chirality. 2007 Jul;19(7):528-35

Mesh Tags

Substances

PMID: 17457831

search → result